The NRG Oncology Podcast
The NRG Oncology Podcast, hosted by Drs. Stephen Chun and Lauren Henke, explores various topics impacting the oncology community through interviews with stakeholders within the NRG Oncology organization.
Episodes
Prostate Cancer Analysis and Translational Science from ASCO 2026
In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.
NRG-GY018 Mature Results from ASCO 2026
Our Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.
Special Episode with ASTRO’s CEO for ASTRO Advocacy Day
The NRG Oncology Podcast discusses the American Society for Radiation Oncology’s (ASTRO) vision and goals, collaborations with cooperative groups such as NRG Oncology, and overcoming obstacles in radiation oncologywith ASTRO’s CEO, Dr. Vivek Kavadi. This is a special episode for ASTRO's 2026 Advocacy Day.
NRG-GY019 Plenary Presentation at SGO 2026
Our co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.
NRG-BR009 and the Importance of Cancer Screening
Our co-hosts discuss the NRG-BR009 'OFSET' study for premenopausal ER-positive/HER2-negative breast cancer patients that have a high risk of cancer returning with study team members Dr. Shannon Puhalla and Dr. Sandra Swain. Also on this episode, we interview Dr. Haane Massarotti on her own experience facing breast cancer as a young adult.
Health Policy, Access, and Patient-Reported Outcomes
American Medical Association President, Dr. Bobby Mukkamala, discusses how his personal experiences in his cancer journey impact his outlook and goals in his AMA Presidency & Dr. James Yu discusses his experiences using patient-reported outcomes from clinical research to help guide health policy.
NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010
Our co-hosts interview NRG-HN009 PI Dr. Paul Harari on the recently reported initial results of NRG-HN009 at the 2026 Multidisciplary Head and Neck Cancer Symposium. Additionally, this episode discusses NRG-HN010 for HER2-expressing salivary gland cancer with Study PI, Dr. Alan Ho.
NRG Protocol Operations Management Committee
Our co-hosts discuss who the NRG Protocol Operations Management "POM" Committee is and what they are responsible for with outgoing Chair, Dr. Maria Werner-Wasik and incoming Chair, Dr. Alexandra Thomas.
Sarcoma in NRG and Through the CT3 Foundation with Special Guests
In the first half of this episode, our co-hosts interview NRG Oncology Sarcoma Subcommittee Chairs, Dr. Dian Wang and Dr. William Tseng on the priorities and goals of the newer subcommittee within NRG's organization.In the second half, our co-hosts meet with MLB Player Chris Taylor and his wife Mary Taylor, the co-founders of the CT3 Foundation to discuss how sarcoma has touched their lives an
The Journal of the American Medical Association (JAMA) with Dr. Bibbins-Domingo
JAMA Editor in Cheif, Dr. Kirsten Bibbins-Domingo discusses JAMA and the JAMA Network and the process for selection and publication of manuscripts.
Smaller Institution Accrual with Dr. Ueno
We take a look at the barriers faced by smaller institutions and rural institutions with Dr. Naoto Ueno of the University of Hawaii in a two-episode series on small vs. larger institution challenges.
Veteran's Day Special Episode with VA-MTF Subcommittee Chair, Dr. Sandulache
Today for Veteran's Day, we discuss the NRG Veteran Affairs and Military Treatment Facility Subcommittee and NCTN trials in the VA system with Subcommittee Chair, Dr. Vlad Sandulache.
NRG-GI011 "LAP100" in Pancreatic Cancer
For Pancreatic Cancer Awareness Month, we discuss the recently activated NRG-GI011 "LAP100" study for locally advanced pancreas cancer with study PI, Dr. Sanford.
Dr. Deborah Bruner Discusses NRG NCORP
Drs. Chun and Henke interview NRG NCORP PI, Dr. Deborah Bruner on the ins-and-outs of the NCI National Community Oncology Research Program (NCORP) as well as her trailblazing career thus far.
NRG at the ASTRO Late-Breaking Session
This episode, our co-hosts discuss the ASTRO late-breaking abstracts that were reported at the ASTRO 2025 annual meeting. Dr. Movsas discusses the quality of life results of NRG-LU005 and Dr. Mehta discusses the proton arm of NRG-BN001. Dr. Steven Frank takes a deeper look at proton implications through the NRG results that were presented at ASTRO.PLEASE NOTE: There is a correction to Dr. Movsas’
NRG at the ASTRO Plenary
NRG Oncology Podcast co-hosts sit with ASTRO President, Dr. Sameer Keole as well as ASTRO Plenary NRG research presenters, Dr. Shannon MacDonald (RadComp) and Dr. Rodney Ellis (NRG-GU005) to discuss results that were reported.
NRG-GU006 at the 2025 ASTRO Clinical Trials Session
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
Dr. Wafik El-Deiry and Precision Oncology & Industry Collaboration
Our co-hosts sit with Dr. El-Deiry for his take on the current state of precision oncology, clinical research, and industry collaborations.
NRG Ancillary Projects with Dr. Waggoner
We interview Dr. Steven Waggoner on the NRG Oncology Ancillary Projects Committee (APC) and the conduct of ancillary projects.
An Interview on the NRG-CC014 "PREEMPT" Study
We interview Dr. Erin Gillespie, PI of the NRG-CC014 "PREEMPT" study comparing radiation therapy to usual therapy for patients with high-risk bone metastases that are not causing pain.
NRG Membership with Dr. David Miller
We interview NRG Deputy Director of Membership and Research Integrity, Dr. David Miller, on the ins-and-outs of NRG Membership and the NRG Membership Committee.
NRG2025 Special: Dr. Bradley, Outgoing NRG Lung Cancer Committee Chair
We interview Dr. Jeff Bradley, the now Immediate Past Chair of the NRG Lung Cancer Committee regarding the past, present, and future of lung cancer in NRG as well as the importance of mentorship for our future research.
NRG-GI003 with Study PI, Dr. Hong
Dr. Ted Hong discusses the NRG-GI003 study comparing proton versus photons for hepatocellular carcinoma.
NRG-CC010 with Dr. Edward Tanner
NRG Oncology Podcast Co-hosts sit with Dr. Edward Tanner, the Principal Investigator of the NRG-CC010 trial assessing the impact of sentinel lymph node mapping on patient-reported lower extremity limb dysfunction in endometrial cancer.
NRG-NSABP B-51/RTOG 1304 Results in NEJM
We discuss the results of NRG-NSABP B-51/RTOG 1304 in breast cancer, reported today in the New England Journal of Medicine.
The NRG-BR003 Results in Triple-Negative Breast Cancer
Our co-hosts discuss triple-negative breast cancer in light of the recently presented results at the 2025 ASCO Annual Meeting. We interview Dr. Vicente Valero, the NRG-BR003 PI, and Dr. Julie Gralow, the Chief Medical Officer of ASCO about these findings and current research in breast cancer.
Patient Advocacy in Clinical Research and the Importance of the Patient-Physician Relationship
The NRG Oncology Podcast Co-hosts sit with NRG Oncology Patient Advocate, Tambre Leighn, to discuss what our patient advocates do in the process of our clinical trials from concept to reporting results. Tambre dives into the benefits of a great patient-physician relationship in building stronger trials as well as the need to tailor our trials around our patients' needs. Tambre also talks about
NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi
NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).
NRG-RTOG 0848 Results in Pancreatic Cancer
Our co-hosts sit with Drs. Ross Abrams and Karyn Goodman to discuss the results of NRG-RTOG 0848 studying adjuvant chemotherapy with or without chemoradiation for patients with resected periampullary pancreatic adenocarcinoma.
An Interview with ASCO CEO, Dr. Hudis
The NRG Oncology Podcast Co-hosts interview Dr. Clifford Hudis - the CEO of the American Society of Clinical Oncology (ASCO) on how ASCO and the NCTN collaborate, the cost and complexity of conducting research, as well as how to take action and advocate for research.
NRG-GI008, the CIRCULATE NA Study, with Drs. Dasari and George
Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
NRG-GU012, the SAMURAI Study, with Dr. William A. Hall
Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.
Interview with George Blasing on the Inspiration of the NRG Oncology Podcast
Our Co-Hosts interview George Blasing of the popular "Dinosaur George" podcast. If you have listened to our prior episodes, George's podcast was the inspiration for the NRG Oncology Podcast in his ability to break down very complex topics to a generalized audience. In this episode, George discusses how he tackles simplifying complex topics and how it can translate into the medical fi
Dr. Wolmark discusses Budgets, Grants, NSABP & NRG, and Breast Cancer Research
We met with Drs. Mannel and Le, so now it is high-time we sit with Dr. Norman Wolmark to complete the NRG Oncology Group Chair trifecta. Dr. Wolmark dives into the NRG budget and grant process and priorities as well as advancements seen in breast cancer research over the years and the role NRG and NSABP play in that.
NRG-BR008, The "HERO" Breast Cancer Trial
The NRG Oncology Podcast Co-hosts sit with NRG-BR008 "HERO" Study Co-PIs Dr. Lior Braunstein and Dr. Melissa Mitchell to discuss this study for low-risk HER2+ breast cancer. This study will test if HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation for patients with early-stage HER2+ breast cancer.
NRG2025 Phoenix Special Episode with Drs. Michalski & Walker
As a special part of the NRG2025 Winter Meeting, we are releasing this two-part interview episode. Our co-hosts sat with Dr. Jeff Michalski, NRG Theranostics Subcommittee Chair, regarding the new subcommittee, its goals, and how it fits into the NRG structure. Additionally, we talk to Dr. Joan Walker who recently stepped down from her role as NRG NCORP Co-PI to focus her efforts in mentorship with
NRG-RTOG/GOG 0724 for Cervical Cancer with Dr. Jhingran
The NRG Oncology Podcast co-hosts interview Dr. Anuja Jhingran to discuss the results of NRG-RTOG/GOG 0724 for cervical cancer in honor of Cervical Cancer Awareness Month.
Medical Oncology with Dr. Langer
Our NRG Oncology Podcast co-hosts interview Dr. Corey Langer on the ins-and-outs of medical oncology, the NRG Oncology Medical Oncology Committee, the evolution of lung cancer trials, and having conversations with patients regarding treatment.
Working with the American Medical Association, Advocacy on the Hill, and Clinical Trial Barriers with Dr. Brown
The NRG Oncology Podcast co-hosts sit with Dr. Anna Brown to discuss the many ways to collaborate with the American Medical Association (AMA), policy and advocacy in action on the Hill, and addressing clinical trial barriers.
DISCLAIMER: The views expressed in this podcast are reflective of Dr. Brown's experiences in nationally elected roles with the AMA but do not represent official opinions of
Surgical Oncology, the NRG-HN006 trial for early-stage oral cavity cancer, and patient language in protocols with Dr. Lai
Drs. Chun and Henke sit down with Dr. Stephen Lai, the NRG Oncology Surgical Oncology Committee Chair and the PI of the NRG-HN006 study of sentinel lymph node biopsy for early stage oral cavity disease. Dr. Lai addresses how surgical oncology fits within the NRG spectrum, his very important study that is actively enrolling patients, and his advocacy and passion for improving patient language on pr
Special ASTRO24 Episode: NRG-LU005 & NRG-HN005 Results
Our co-hosts interview Drs. Kristin Higgins and Dr. Sue Yom on the results of NRG-LU005 (chemo +/- atezo in limited-stage small cell lung cancer) and NRG-HN005 (de-intensified RT for Early-stage p16+ oropharyngeal cancer) presented during the 2024 ASTRO Plenary Session.
Gynecologic Oncology, Disparities, and Early Career Investigators with Dr. Mannel
The NRG Oncology Podcast Co-hosts interview Group Chair Robert Mannel on ongoing efforts in gynecologic oncology research, a timely episode to be issued during Gynecologic Cancer Awareness Month! Dr. Mannel also touches base on the health disparities in gynecologic oncology as well as advice for early career investigators.
NRG-LU002 Results and Impact with Dr. Iyengar
The NRG Podcast co-hosts interview Dr. Puneeth Iyengar on the recently presented NRG-LU002 results from ASCO 2024. NRG-LU002 studies maintenance systemic therapy versus local consolidative therapy plus maintenance systemic therapy for patients with limited-metastatic non-small cell lung cancer.
An NRG Oncology Overview with Dr. Le
Dr. Quynh-Thu Le, one of the NRG Oncology Group Chairs, discusses the ins-and-outs and current goals of the organization.
Recommended
10000 MINUTES
1000 Things You Should Know
1000x
1001 Classic Short Stories & Tales
1001raah | هزار و یک راه
1001 Sherlock Holmes Stories & The Best of Sir Arthur Conan Doyle
1001 Songs That Make You Want To Die
100 Famous Dogs
#100MasterCoaches with Mel Leow, MCC
100% Mixtape Podcast
100 With The Hunter's
10-41: A UCSO Podcast
